Evofem Biosciences, Inc. (EVFM) — Cost of Revenue
| Fiscal Year | Cost of Revenue | Change YoY |
|---|---|---|
| 2025 | $4.62M | +20.4% |
| 2024 | $3.83M | -41.1% |
| 2023 | $6.51M | +47.5% |
| 2022 | $4.42M | +8.9% |
| 2021 | $4.05M | +766.5% |
| 2020 | $468.0K | — |
| 2019 | $0 | — |
| Fiscal Year | Cost of Revenue | Change YoY |
|---|---|---|
| 2025 | $4.62M | +20.4% |
| 2024 | $3.83M | -41.1% |
| 2023 | $6.51M | +47.5% |
| 2022 | $4.42M | +8.9% |
| 2021 | $4.05M | +766.5% |
| 2020 | $468.0K | — |
| 2019 | $0 | — |